METACRINE
Metacrine is a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases. The most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. Beyond the FXR program, a pipeline of novel drug candidates against other drug targets is being explored by taking advantage of internal drug discovery and development capabilities.
METACRINE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.metacrine.com
Total Employee:
11+
Status:
Active
Contact:
(858) 369-7800
Email Addresses:
[email protected]
Total Funding:
173 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Adlai Nortye
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Immunovant
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Debt Financing - Metacrine
Polaris Partners
Polaris Partners investment in Series C - Metacrine
ArrowMark Partners
ArrowMark Partners investment in Series C - Metacrine
Franklin Templeton Investments
Franklin Templeton Investments investment in Series C - Metacrine
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - Metacrine
Deerfield Capital Management
Deerfield Capital Management investment in Series C - Metacrine
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Metacrine
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Metacrine
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Metacrine
Invus
Invus investment in Series C - Metacrine
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-24 | Metacrine Announces Executive Leadership Changes |
Official Site Inspections
http://www.metacrine.com Semrush global rank: 9.41 M Semrush visits lastest month: 160
- Host name: 70.31.225.35.bc.googleusercontent.com
- IP address: 35.225.31.70
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Metacrine"
Home - Metacrine
We are an experienced team with internal drug discovery and development expertise focused on building a pipeline of best-in-class oral drugs for liver and gastrointestinal diseases.See details»
Metacrine - Crunchbase Company Profile & Funding
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. View contacts for Metacrine to access new leads and connect …See details»
Leadership & Board of Directors - Metacrine
© 2024 Metacrine | 231 Market Pl, Suite 373, San Ramon, CA 94583 Leadership & Board of Directors; Investors Financials & Filings; Sec Filings; Investor ResourcesSee details»
Metacrine Announces Appointment of Dr. Ken Song as President …
San Diego, CA – Metacrine, Inc., a biotechnology company focused on developing innovative therapeutics in metabolic disease through advances in endocrine research, today announced …See details»
Metacrine Company Profile 2024: Valuation, Funding & Investors
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its …See details»
Metacrine, Inc. - LinkedIn
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal (GI) diseases. Our most advanced programs target the...See details»
Metacrine Company Profile - Office Locations, Competitors, …
Metacrine is a biotech company developing innovative therapeutics for metabolic diseases. The company is led by an experienced management team and backed by leading institutional …See details»
Metacrine Inc (MTCR) Stock Price and News - The Globe and Mail
Metacrine Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing therapies for patients with liver and gastrointestinal diseases. The company's...See details»
Equillium to Acquire Metacrine in All-Stock Transaction
Sep 6, 2022 · LA JOLLA, Calif.-- ( BUSINESS WIRE )--Equillium, Inc. (Nasdaq: EQ) and Metacrine Inc. (Nasdaq: MTCR), today announced that the two companies have entered into a definitive merger agreement...See details»
Metacrine, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Metacrine, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 32 news, and 2 literature, Technology Platform:Chemical drugs, Small molecule drug, …See details»
Equillium - Equillium and Metacrine Mutually Agree to Terminate ...
Dec 23, 2022 · Equillium, Inc. (Nasdaq: EQ) and Metacrine, Inc. today announced the mutual termination of their previously announced definitive merger agreement.See details»
Metacrine Broadens Management Team with Two Key Hires
San Diego, CA – Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced two new …See details»
Metacrine Updates IBD Clinical Development Strategy and …
Feb 11, 2022 · Metacrine has received authorization from the U.S. Food and Drug Administration (FDA) to proceed with its Phase 2 trial evaluating MET642 in subjects with inflammatory bowel …See details»
Metacrine Updates MET642 Clinical Development Milestone and …
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with …See details»
Metacrine, Inc. (MTCR) 10K Annual Reports & 10Q SEC Filings
Mar 30, 2022 · - Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, today reported …See details»
Metacrine Presents Positive MET409 Phase 1b Clinical Data in …
Aug 27, 2020 · Metacrine is a clinical-stage biopharmaceutical company building a differentiated pipeline of drugs to treat liver and gastrointestinal (GI) diseases. The company’s most …See details»
Metacrine to Present Final Results from Phase 1 Trial of MET642, …
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing …See details»
Metacrine Achieves Full Enrollment for MET642 Phase 2a
SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with …See details»
Equillium to Acquire Metacrine in All-Stock Transaction
Sep 6, 2022 · LA JOLLA, Calif.-- (BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ) and Metacrine Inc. (Nasdaq: MTCR), today announced that the two companies have entered into a definitive …See details»